...Thank you. Good morning, good afternoon, everyone. I'm pleased to introduce you to the Post Pandemic Recovery SPAC with its specified target, Napo EU, which is a subsidiary being established by Jaguar Health in Italy. Jaguar participated in a test-the-waters roadshow with me in December, which contemplated this proposed SPAC. The roadshow included approximately 150 European institutional investors in 4 countries and 6 cities. We were very encouraged by the positive indications of interest expressed with this opportunity, and we have recently launched our website for the PPR SPAC which is postpandemicspac.com. You can go there for regular updates on our progress. The recent news about more virulent strains of the coronavirus are obviously emerging right around the world. And this makes 1 factor very clear: By the summer of '22, the point when we hope that the U.S. and EU will have developed herd immunity, as much as 50% of the adult population may have been infected at least once. So what...
